Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Machine Learning Models for Predicting Long-Term Clinical Outcomes in Chinese Female Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT06856616 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT06856616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06856616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Machine Learning Models for Predicting Long-Term Clinical Outcomes in Chinese Female Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Lead sponsor
The Third Affiliated Hospital of Harbin Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
May 13, 2025
Completion date
June 1, 2026
Enrollment
6,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms